Research Study

Evaluation of XIENCE Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization
Principal Investigator 
Jaap N. Hamburger

Overview

Body Locations and Systems 
ClinicalTrials.gov# 
NCT01205776
Status 
Closed to Recruitment
Study Start/End 
Apr 26, 2011 to Jan 31, 2021
Locations 
Vancouver General Hospital
Name/Title 
Andriy Starovoytov, Research Coordinator
Phone 
604-875-5079
Email Address 
a.starovoytov@ubc.ca
Purpose of Study 

To establish the safety and efficacy of the commercially approved XIENCE Family Stent System (inclusive of XIENCE PRIME, XIENCE V, XIENCE Xpedition and XIENCE PRO [for use outside the United States [OUS] only]) in subjects with unprotected left main coronary artery disease by comparing to coronary artery bypass graft surgery.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.